Company profile

Hangzhou Zhongmei Huadong Pharmaceutical

Diversified pharma / peptide therapeutics

000963 · SZSE · China

Public Market Listing

000963SZSE

SZSE primary exchange listing

Live quotes, historical charts, and market capitalization for Hangzhou Zhongmei Huadong Pharmaceutical are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(5 total)
5Total Assets
0Approved
3Phase 3 / Filed
2Phase 1–2 / Early
4Diseases
Quick filter:
Showing 5 of 5 assets
Target & Modality
HDG1901
Phase 3
GLP-1 receptorSmall molecule
Type 2 Diabetes
HDM1002
Phase 3
GLP-1 receptorSmall molecule
Obesity
HDM1005
Phase 3
GLP-1/GIP receptor (dual)Peptide
Obesity
HDM2020
Phase 1
FGFR2bAntibody–drug conjugate
Non-Small Cell Lung Cancer
Ganagliflozin
Preclinical
Sodium-glucose cotransporter 2 (SGLT2)Small molecule
Chronic Kidney Disease

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.